Masimo Corp Chief Executive Joe Kiani has waived his rights for roughly $600 million in special payment if the U.S. medical device maker appoints a lead independent director, the company said on Thursday. The company, which named board member Michael Cohen as a lead independent director, said Kiani has also agreed that a move by […]
Masimo Corporation (MASI) announced several changes to its board of directors on Thursday amid a proxy battle with ctivist investor Politan Capital Management. Read the full story here.
Masimo Corporation is a healthcare business that intends to improve the quality of life of its customers. Read more to see why MASI stock is a Buy.
Masimo Corporation shares fell off a cliff early in 2022 amidst the pullback in momentum names and a poorly received deal for Sound. Click here for more on MASI.
Technologies Like Masimo SpHb Offer a "Practical Approach" to Perioperative Blood Management and "Timely Detection of Changes" Masimo (NASDAQ: MASI) today announced that updated guidelines publish…
Masimo (NASDAQ: MASI) today announced that updated guidelines published by the European Society of Anaesthesiology and Intensive Care (ESAIC) highlight the value of noninvasive, continuous hemoglobin (Hb) monitoring in helping clinicians manage perioperative bleeding. Referencing studies using technologies such as Masimo SpHb, the guidelines note that “the use of noninvasive Hb-monitoring methods
Masimo (NASDAQ: MASI) today announced the findings of a prospective study published in Pediatrics International in which Dr. Ya-Fei Liu and colleagues at Peking University First Hospital in Beijing evaluated the ability of noninvasive, continuous Masimo PVi, alongside other dynamic parameters, to predict fluid responsiveness in children 1-3 years old who were undergoing major neurosurgery. The
IRVINE, Calif. & PHILADELPHIA--(BUSINESS WIRE)--Masimo and Temple Health are entering into a strategic innovation collaboration focused on hospital automation and telehealth.
Researchers Found That Noninvasive, Continuous PVi Was Equally Effective in Guiding Fluid Management As Stroke Volume Variation (SVV), an Invasive Method Requiring an Arterial Line NEUCHATEL, Switzerland — Masimo (NASDAQ: MASI) today announced the findings of a prospective study published in the British Journal of Neurosurgery in which Dr. Ankita Dey and colleagues at institutions […]
Masimo (NASDAQ: MASI) today announced the findings of a prospective study published in the British Journal of Neurosurgery in which Dr. Ankita Dey and colleagues at institutions in Bathinda and Pondicherry, India evaluated the use of noninvasive, continuous Masimo PVi, as part of goal-directed fluid therapy (GDFT), to guide intraoperative fluid administration during neurosurgery – the first study
NEW YORK--(BUSINESS WIRE)--Politan Capital Management (together with its affiliates, “Politan”), a 9% stockholder of Masimo Corporation (“Masimo” or the “Company”) (NASDAQ: MASI) today announced that the California State Teachers’ Retirement System (CalSTRS) has joined Politan’s ongoing legal action against Masimo and its Board of Directors (the “Board”). Politan’s lawsuit, filed in the Court of Chancery of the State of Delaware, challenges the validity and legality of the employment agreement
The $311 billion California state teachers pension fund is teaming up with an activist investor to stop Masimo Corp''s chief from receiving over half a billion dollars if there are changes to the U.S. medical device maker''s corporate governance, including its board of directors.
NEW YORK — The $311 billion California state teachers pension fund is teaming up with an activist investor to stop Masimo Corp’s chief from receiving over half a billion dollars if there are changes to the U.S. medical device maker’s corporate governance, including its board of directors. The California State Teachers’ Retirement System (CalSTRS) told […]
IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today announced that its management will participate in the 44th Annual Raymond James Institutional Investors on Tuesday, March 7, 2023 at 11:00 a.m. Eastern Time. A live webcast of the presentation will be available on the Masimo website at www.masimo.com. A replay of the webcast will be available following the live presentation. About Masimo Masimo (NASDAQ: MASI) is a global medical technology company that develops and produces a wide arr
The following slide deck was published by Masimo Corporation in conjunction with their 2022 Q4 earnings call.
Masimo press release (MASI): Q4 Non-GAAP EPS of $1.32 beats by $0.14.Revenue of $617M (+88.4% Y/Y) beats by $14.51M.Full-Year 2022 Highlights:Consolidated revenue was…
IRVINE, Calif.--(BUSINESS WIRE)--Masimo (Nasdaq: MASI) today announced its financial results for the fourth quarter and full-year ended December 31, 2022. Fourth Quarter 2022 Results: Consolidated revenue was $617.0 million, representing 88.3% reported growth. Healthcare revenue was $351.9 million, representing 7.4% reported growth and 10.1% growth on a constant currency basis. Non-healthcare revenue was $265.1 million. Excluding handheld and fingertip pulse oximeters, shipments of noninvasive
Raymond James upgraded Masimo Corporation (NASDAQ: MASI ) from Market Perform To Outperform with a price target of $187 and says that no other company in its coverage offers as many paths to incremental value creation. The analyst writes that the stock setup seems attractive despite the uncomfortable headline P/E multiple. A vibrant pipeline adds new growth drivers and potential upside to year estimates. The analyst sees the 2H23 approval/launch of Stork (baby monitor) … Full story available on Benzinga.com
Raymond James upgraded Masimo Corporation (MASI) on Wednesday, expecting the MedTech company to beat Street forecasts when it issues Q4 financials next week. Read the full story here.
The Biden administration has declined to overrule a U.S. International Trade Commission decision that the Apple Watch infringes patents from medical device company AliveCor, potentially paving the way for an import ban on Apple''s smartwatch depending on how the appeals process pans out. California-based AliveCor said in a statement that it was informed the Biden administration would not overrule a December decision from the ITC that found the Apple Watch infringed AliveCor health monitoring patents related to electrocardiogram technology. From AliveCor''s press release : "We applaud President Biden for upholding the ITC''s ruling and holding Apple accountable for infringing the patents that underpin our industry-leading ECG technology," said Priya Abani, CEO of AliveCor. "This decision goes beyond AliveCor and sends a clear message to innovators that the U.S. will protect patents to build and scale new technologies that benefit consumers." In the December ruling, the ITC recommended a limited exclusion order and a cease-and-desist order for Apple Watch models with ECG features.
Masimo (NASDAQ: MASI) today announced the findings of a prospective, double-blinded, randomized controlled study published in Medicine in which Dr. Jin Hee Ahn and colleagues at the Sungkyunkwan University School of Medicine in Seoul, Korea, evaluated the ability of Masimo ORi to assist clinicians in guiding supplemental oxygenation during elective laparoscopic gastrectomy surgery. The researchers
Related Stocks: ST , AVLR , HALO , LH , MASI ,
Masimo (NASDAQ: MASI) will release fourth quarter and FY 2022 financial results for the period ended December 31, 2022, after the market closes on Tue
NEW YORK — U.S. medical device maker Masimo Corp changed its bylaws on Monday to stop requiring hedge funds to detail top secret data, ending, for now, a debate over how far corporate America will go to defend against agitating investors. The decision removes bylaw amendments adopted in September that required anyone nominating directors to […]
Medical device maker Masimo Corp on Monday said it changed its bylaws to eliminate requirements that would have forced investors seeking to nominate directors to the firm to reveal information that hedge funds consider to be top secret.
In February, Masimo announced it''s acquisition of Sound United. Can MASI properly commercialize the opportunities? Click here to find out.
ST. PETERSBURG, Fla. , Feb. 1, 2023 /PRNewswire/ -- January 30, 2023 , McGowan Allied Specialty (MASI) Insurance hires Joe James as a Senior Producer. McGowan Allied Specialty Insurance (MASI), the premier provider of commercial insurance products to the amusement industry, has announced the hiring of Joe James as a Senior Producer. James brings 35 years of sales experience to McGowan Allied Specialty Insurance, with his last 23 in specialty sales for the Amusement Industry, offering risk analysis to prospects and clients with a keen focus on their unique needs. He worked directly with insureds to provide honest … Full story available on Benzinga.com